Recurrence of Philadelphia Chromosome-Positive Leukemia in Donor Cells after Bone Marrow Transplantation for Chronic Granulocytic Leukemia

References

• Chao N. J., Forman S. J., Schmidt G. M., Snyder D. S., Amylon M. D., Konrad P. N., Nademanee A. P., O'Don-nell M. R., Parker P. M., Stein A. S., Smith E., Wong R. M., Hoppe R. T., Blume K. G. Allogeneic bone marrow transplantation for high risk acute lymphoblastic leukemia during first complete remission. Blood 1991; 78: 1923–1927
   PubMed Web of Science ®Google Scholar
• Sanders J. E., Thomas E. D., Buckner E. D., Doney K. Marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood 1987; 70: 324–326
   PubMed Web of Science ®Google Scholar
• McGlave P. Bone Marrow transplants in chronic my-elogenous leukemia: an overview of determinants of survival. Semin. Hematol. 1990; 27, 3, (Suppl 4): 23–30
   Web of Science ®Google Scholar
• Conde E., Iriondo A., Rayon C., Richard C., Fanjul E., Garijo J., Hermosa V., Coma A., Bello C., Carrera D., Baro J., Zubizaretta A. Allogeneic bone marrow transplantation versus intensive chemotherapy for acute my-elogenous leukemia in first remission: a prospective control trial. Br. J. Haematol. 1988; 68: 219–226
   PubMed Web of Science ®Google Scholar
• Thomas E. D., Clift R. A., Fefer A., Appelbaum F. R., Beatty P., Bensinger W. I., Buckner C. D., Cheever M. A., Deeg H. J., Doney K., Fluornoy N., Greenberg P., Hansen J. A., Martin P., McGuffin R., Ramberg R., Sanders J. E., Singer J., Stewart P., Storb R., Sullivan K., Weiden P. L., Witherspoon R. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann. Iniern. Med. 1986; 104: 155–163
   PubMed Web of Science ®Google Scholar
• Thomas E. D., Clift R. A. Indications for marrow transplantation in chronic myelogenous leukemia. Blood 1989; 73: 861–864
   PubMed Web of Science ®Google Scholar
• Seeker Walker L. M., Craig J. M., Hawkins J. M., Hoffbrand A. V. Philadelphia positive acute lympho-cytic leukemia in adults: age distribution, BCR breakpoint and prognostic significance. Leukemia 1991; 5: 196–199
   PubMed Web of Science ®Google Scholar
• Goldman J. M., Gale R. P., Horowitz M. M., Biggs J. C., Champlin R. E., Gluckman E., Hoffman R. G., Ja-cobsen S. J., Marmont A. M., McGlave P. B., Messner H. A., Rimm A. A., Rozman C., Speck B., Tura S., Weiner R. S., Bortin M. M. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk of relapse associated with T cell depletion. Ann. Intern. Med. 1988; 108: 806–814
   PubMed Web of Science ®Google Scholar
• Horowitz M. M., Gale R. P., Sondel P. M., Goldman J. M., Kersey J., Kolb H. J., Rimm A. A., Ringden O., Rozman C., Speck B., Truitt R. L., Zwann F. E., Bortin M. M. Graft versus leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555–562
   PubMed Web of Science ®Google Scholar
• Hook E. B. Exclusion of chromosomal mosaicism. tables of 90%, 95% and 99% confidence limits and comments on their use. Am. J. Hum. Genet. 1977; 29: 94–97
   PubMed Web of Science ®Google Scholar
• Lawler S. D., Baker M. C., Harris H., Morgenstern G. R. Cytogenetic studies on recipients of allogeneic bone marrow using sex chromosomes as markers of cellular origin. Br. J. Haematol. 1984; 56: 431–443
   PubMed Web of Science ®Google Scholar
• Ginsberg D., Antin J. H., Smith B. R., Orkin S. H., Rappeport J. M. Origin of cell populations after bone marrow transplantation; analysis using DNA sequence polymorphisms. J. Clin. Invest. 1985; 75: 596–603
   PubMed Web of Science ®Google Scholar
• Blazar B. R., Orr H. T., Arthur D. C., Kersey J. H., Filipovitch A. H. Restriction fragment length polymorphisms as markers of engraftment in allogeneic marrow transplantation. Blood 1985; 66: 1436–1444
   PubMed Web of Science ®Google Scholar
• Petz L. D., Yam P., Wallace R. B., Stock D., de Lange G., Knowlton R., Brown V. A., Donis Keller H., Hill R., Forman S. J., Blume K. G. Mixed hemato-poietic chimerism following bone marrow transplantation for hématologie malignancies. Blood 1987; 70: 1331–1337
   PubMed Web of Science ®Google Scholar
• Lawler M., Humphries P., McCann S. R. Evaluation of mixed chimerism by in vitro amplification of dinu-cleotide repeat sequences. Blood 1991; 77: 2504–2514
   PubMed Web of Science ®Google Scholar
• Bertheas M. F., Lafage M., Levy P., Blaise D., Stoppa A. M., Viens P., Mannoni P., Maraninchi D. Influence of mixed chimerism on the results of allogeneic bone marrow transplantation for leukemia. Blood 1991; 78: 3103–3106
   PubMed Web of Science ®Google Scholar
• Roth M. S., Antin J. H., Bingham E. L., Ginsburg D. Detection of Philadelphia chromosome positive cells by the polymerase chain reaction following bone marrow transplantation for chronic myelogenous leukemia. Blood 1989; 74: 882–885
   PubMed Web of Science ®Google Scholar
• Hughes T. P., Goldman J. M. Biological importance of residual leukemia cells after bone marrow transplantation for chronic myeloid leukemia: does the polymerase chain reaction help?. Bone Marrow Transplant. 1990; 5: 3–6
   PubMed Web of Science ®Google Scholar
• Fiaklow P. J., Thomas E. D., Bryant J. I., Neiman P. E. Leukaemic transformation of engrafted human marrow cells in vivo. Lancet 1971; i: 251–255
   Google Scholar
• Thomas E. D., Bryant J. I., Buckner C. D., Clift R. A., Fefer A., Johnson F. L., Neiman P., Ramberg R. E., Storb R. Leukaemic transformation of engrafted human marrow cells in vivo. Lancet 1972; i: 1310–1313
   Google Scholar
• Newburger P. E., Latt S. A., Pesandro J. M., Gustashaw K., Powers M., Chaganti R. S., O'Reilly R. J. Leukemia relapse in donor cells after allogeneic bone marrow transplantation. N. Engl. J. Med. 1981; 304: 712–714
   PubMed Web of Science ®Google Scholar
• Witherspoon R. P., Schubach W., Neiman P., Martin P., Thomas E. D. Donor cell leukemia developing six years after marrow grafting for acute leukemia. Blood 1985; 65: 1172–1174
   PubMed Web of Science ®Google Scholar
• Schmidz N., Johannsen W., Schmidt G., von der Helm K., Loffler H. Recurrence of acute lymphoblastic leukemia in donor cells after allogeneic marrow transplantation associated with a deletion of the long arm of chromosome 6. Blood 1987; 70: 1099–1104
   PubMed Web of Science ®Google Scholar
• Zacaria A., Rosti G., Testoni N., Arnold R., Bandini G., Becher R., Boogaerts M., Carboneil F., Di Bartolomeo P., Ferrant A. Chromosome studies in patients with acute nonlymphocytic or acute lymphocytic leukemia submitted to bone marrow transplantation-results of a European cooperative study. Cancer Genet. Cytogenet. 1987; 26: 51–58
   PubMed Web of Science ®Google Scholar
• Feig S. A., Dreazen O., Simon M., Wiley F., Schreck R., Gale R. P. B cell acute lymphoblastic leu-kemia(ALL) in donor cells following bone marrow transplantation for T cell ALL. Bone Marrow Transplant. 1988; 3: 331–337
   PubMed Web of Science ®Google Scholar
• Goh K., Klemperer M. R. In vivo leukemic transformation: cytogenetic evidence of in vivo leukemic transformation of engrafted marrow cells. Am. J. Hematol. 1977; 2: 283–290
   PubMed Web of Science ®Google Scholar
• Elfenbein G. J., Borgaonkar D. S., Bias W. B., Burns W. H., Saral R., Sensenbrenner L. L., Tutschka P. J., Zaczek B. S., Zander A. R., Epstein R. B., Rowley J. D., Santos G. W. Cytogenetic evidence for recurrence of acute myelogenous leukemia after allogeneic bone marrow transplantation in donor hematopoietic cells. Blood 1978; 52: 627–636
   PubMed Web of Science ®Google Scholar
• Browne P. V., Lawler M., Humphries P., McCann S. R. Donor-cell leukemia after bone marrow transplantation for severe aplastic anemia. N. Engl. J. Med. 1991; 325: 710–713
   PubMed Web of Science ®Google Scholar
• Gosset T. C., Gale R. P., Fleischman H., Austin G. E., Sparkes R. S., Taylor C. R. Immunoblastic sarcoma in donor cells after bone marrow transplantation. N. Engl. J. Med. 1979; 300: 904–907
   PubMed Web of Science ®Google Scholar
• Schubach W. H., Hackman R., Neiman P. E., Miller G., Thomas E. D. A monoclonal immunoblastic sarcoma in donor cells bearing Epstein barr virus genomes following allogeneic marrow grafting for acute lymphoblastic leukemia. Blood 1982; 60: 180–187
   PubMed Web of Science ®Google Scholar
• Deeg H. J., Sanders J., Martin P., Fefer A., Neiman P., Singer J., Storb R., Thomas E. D. Secondary malignancies after marrow transplantation. Exp. Hematol. 1984; 12: 660–668
   PubMed Web of Science ®Google Scholar
• Arthur C. K., Apperley J. F., Guo A. P., Rassool F., Gao L. M., Goldman J. M. Cytogenetic events after bone marrow transplantation for chronic myeloid leukemia in chronic phase. Blood 1988; 71: 1179–1186
   PubMed Web of Science ®Google Scholar
• Smith J. L., Heerema N. A., Provisor A. J. Leukaemic transformation of engrafted bone marrow cells. Br. J. Haematol. 1985; 60: 415–422
   PubMed Web of Science ®Google Scholar
• Witherspoon R. P., Fisher L. D., Schoch G., Martin P., Sullivan K. M., Sanders J., Deeg H. J., Doney K., Thomas D., Storb R., Thomas E. D. N. Engl. J. Med. 1989; 321: 784–789
   PubMed Web of Science ®Google Scholar
• Marmonl A., Frassoni F., Bacigalupo A., Podesta M., Piaggo G., Van Lint M. T., Caimo A., DeFilippi S. Recurrence of Ph' positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia. N. Engl. J. Med. 1984; 310: 903–906
   PubMed Web of Science ®Google Scholar
• McCann S. R., Lawler M., Humphries P., Bacigalupo A., Van Lint M. T., Frassoni F., Podesta M., Marmont A. Recurrence of Ph' positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia: confirmation of the donor origin of cells by microsatellite studies. Blood 1992; 79: 2803–2805
   PubMed Web of Science ®Google Scholar
• Padre Mendosa T., Fames P., Barker B. E., Smith P. S., Forman E. N. Y chromosome loss in childhood leukaemias. Br. J. Haematol. 1979; 41: 43–48
   PubMed Web of Science ®Google Scholar
• Stein J., Zimmerman P. A., Kochera M., Strandjord S., Golden W., Simon M., Warketin P., Blazar B. R., Coccia P., Lang Unnasch N. Origin of leukemic relapse after bone marrow transplantation: comparison of cytogenetic and molecular analyses. Blood 1989; 73: 2033–2040
   PubMed Web of Science ®Google Scholar
• Biondi A., Norman C., Messner H. A., Minden M. D. Restriction fragment length polymorphism analysis of hematopoietic cells following successful treatment of relapsed acute lymphoblastic leukemia following bone marrow transplantation. Bone Marrow Transplant. 1989; 4: 705–709
   PubMed Web of Science ®Google Scholar
• Naoe T., Kiyoi H., Yamanaka K., Naito K., Yamada K. A case of cALL relapse after allogeneic BMT: recurrence of recipient cell origin, initially determined as being of donor origin by sex chromosome analysis. Br. J. Haematol. 1989; 73: 420–422
   PubMed Web of Science ®Google Scholar
• Niedersweiser D. W., Applebaum F. R., Gastl G., Gersdorf E., Meister B., Geissler D., Tratkiewicz J. A., Thaler J., Huber C. In advenant transmission of a donors acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia. N. Engt. J. Med. 1990; 322: 1794–1796
   PubMed Web of Science ®Google Scholar
• Casciato D. A., Scott J. L. Acute leukemia following prolonged cytotoxic agent therapy. Medicine 1979; 58: 32–47
   PubMed Web of Science ®Google Scholar
• Riche K. Carcinogenicity of antneoplastic drugs in man. Cancer Treatment Rev. 1984; 11: 39–67
   PubMed Web of Science ®Google Scholar
• Kaplan H. S. On the natural history of the murine leukemias: presidential address. Cancer Res. 1967; 27: 1325–1340
   PubMed Web of Science ®Google Scholar
• Adams J. M., Cory S. Transgenic models of tumor development. Science 1991; 254: 1161–1167
   PubMed Web of Science ®Google Scholar
• Rowe M. Epstein barr virus and lymphoid malignancy. Recent Advances in Hematologw, A. V. Hoff-brand, M. K. Brenner. Churchill Livingstone, Edinburgh 1992; Vol. 6: 209–226
   Google Scholar
• Ben Neriah Y., Daley G. Q., Mes-Masson A. M., Witte O. N., Baltimore D. The chronic myelogenous leukemia specific p210 protein is the product of the bcr/abl hybrid gene. Science 1986; 233: 212–214
   PubMed Web of Science ®Google Scholar
• Lugo T. G., Pendergast A. M., Müller A. J., Witte O. N. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 1990; 247: 1079–1082
   PubMed Web of Science ®Google Scholar
• Daley G. Q., Van Etten R. A., Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210*** gene of the Philadelphia chromosome. Science 1990; 247: 824–830
   PubMed Web of Science ®Google Scholar
• Fiaklow P. J., Martin P. J., Najfeld V., Penfold G. K., Jacobsen R. J., Hansen J. A. Evidence for a multistep pathogenesis of chronic myelogenous leukemia. Blood 1981; 58: 158–163
   PubMed Web of Science ®Google Scholar
• Greaves M. F. Target cells, differentiation and clonal evolution in chronic granulocytic leukaemia: a “model” for understanding the biology of malignancy. Chronic Granulocytic Leukaemia, M. T. Shaw. Praeger, London 1982; 15–47
   Google Scholar
• Feinstein E., Cimino G., Gale R. P., Alimena G., Be-thier R., Kishi K., Goldman J. M., Zacearia A., Berrebi A., Canaani E. p53 in chronic myelogenous leukemia in acute phase. Proc. Nat. Acad. Sei. USA 1991; 88: 6293–6297
   PubMed Web of Science ®Google Scholar
• Yoshida M., Seiki M., Yamaguchi K., Takatsuki K. Monoclonal integration of human T cell leukemia pro-virus and in all primary tumors of adult T cell leukemia suggest causative role of human T-cell leukemia virus in the disease. Proc. Nat. Acad. Sci. USA 1984; 81: 2534–2537
   PubMed Web of Science ®Google Scholar
• Simmons P. J., Przepiorka D., Thomas E. D., Torok Storb B. Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature 1987; 328: 429–432
   PubMed Web of Science ®Google Scholar
• Santucci M. A., Trabetti E., Martinelli G., Buzzi M., Zacearía A., Pileri S., Farabegloi P., Sabattini E., Tura S., Pignatti P. F. Host origin of bone marrow fibroblasts following allogeneic bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant. 1992; 10: 255–259
   PubMed Web of Science ®Google Scholar
• Wetzler M., Kurzrock R., Lowe D. G., Kantarjian H., Gutterman J. U., Talpaz M. Alteration in bone marrow adherent layer growth factor expression: a novel mechanism of chronic myelogenous leukemia progression. Blood 1991; 78: 2400–2406
   PubMed Web of Science ®Google Scholar
• Russell P. J., Brown J., Grimmond S., Stapleton P., Russell P., Raghavan D., Symonds G. Tumour induced host stromal cell transformation: induction of mouse spindle cell fibrosarcoma not mediated by gene transfer. Int. J. Cancer 1990; 46: 299–309
   PubMed Web of Science ®Google Scholar